Ann: Investor, page-157

First 157 Last

Share
Profile

Follow
sparkster

39 Posts.

13

11/06/21

18:19

Post #: 53802565
Share

Originally posted by Fact Finder: ↑

Ok my few takeaways from this presentation:

1. Peter van der Made was nervous but only because he is not used to speaking to a short time limit. Note his comment when he finished he was worried all the way through he would go overtime and not finish. This is a public speaking skill that can be learned but not in the time he will be acting CEO. All the teachers and lawyer advocates will understand this to be true.

2. Data centres - Posters will remember last year we had a downramper who came on here and ridiculed myself and uiux ect; over suggesting AKIDA could be used in Data Centres to save power. Claimed to be technology literate.

3. Data centres - Use a huge proportion of their power to process CNN deep learning so go back to the podcast with Rob Lincourt from DELL Technologies and listen to him speak about the potential for AKIDA to be scaled up to operate as a co- processor with servers in a Data Centre offloading the high loads created processing CNN deep learning.

4. Renesas - They have paid their licence fee and are working on incorporating the IP into their chips and once done and tested and those products are released royalties will start to flow.

5. Fridges - In a presentation where he was worried about getting the important information out he still spoke about fridges and AKD500 being produced and used in Fridges. Anyone else getting the clear message about fridges.

6. Smart Door Bells. - Same thing time constrained but still like Roger Levinson, Lou Dinardo, Anil Mankar he found time to talk about Smart Door Bells and this time suggested they will be doing a whole lot more.

7. NaNose - Mentioned cancer detection first before he mentioned Covid and did not return to it so I refer you back to the NaNose video for a handheld device identifying 17 different cancers from VOC’s and listing Brainchip as their Strategic Partner. How big is the cancer detection market. If you listened to the two previous presenters you will know the answer and how important early detection is to saving lives.

There is more but I think they have been well covered by others except that this presentation will be made available next week and the presenter let slip, I believe, that they will be doing more with Peter van der Made next week.

My opinion only DYOR
FF

AKIDA Ballista

Expand

I've spoken about Akidas application to data centres and my confusion as to why BRN (unlike its competitors) constrains it focus on the edge, something LDN said himself in interviews.

https://hotcopper.com.au/understanding-triterras-current-and-future-valuation.6016643/page-72?post_id=52657682

you labelled me a downramper despite my being bullish on BRN real world applications .

BRN Price at posting: 56.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PIQ

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

REA

UK-based Rightmove knocks back REA Group's acquisition proposal

MAY

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

LU7

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

There are more pages in this discussion • 201 more messages in this thread...

First 157 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 16.0¢		Change 0.005(3.23%)		Mkt cap ! $313.9M

Open	High	Low	Value	Volume
16.0¢	16.5¢	15.8¢	$333.3K	2.083M

Buyers (Bids)

No.	Vol.	Price($)
18	117924	16.0¢

Sellers (Offers)

Price($)	Vol.	No.
16.5¢	1667806	45

View Market Depth

No.	Vol.	Price($)
15	79168	0.160
66	2452895	0.155
129	4217889	0.150
38	931712	0.145
42	1150394	0.140

Price($)	Vol.	No.
0.165	1667955	45
0.170	1285218	30
0.175	1067675	15
0.180	1447476	19
0.185	684576	22

Last trade - 15.33pm 11/09/2024 (20 minute delay)

BRN (ASX) Chart

Ann: Investor, page-157

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

UK-based Rightmove knocks back REA Group's acquisition proposal

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Investor, page-157

Top Stories

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

UK-based Rightmove knocks back REA Group's acquisition proposal

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News